Since cancer stem cells are believed to provide GBM recurrence [18], chemoresistance [19–21] and radio resistance [22, 23], we maintained these cells in stem cell mimicking conditions (as described in the materials and method section) to preserve stemness and characterized them for the expression of DSG2, CD46 and CAR markers. Here, DSG2 is linked to glioblastoma.